Alzheimer's Disease (AD) is associated with behavioural disturbances such as restlessness and agitation that are exacerbated in late afternoon or early evening, sometimes referred to as "sundowning". The day/night rhythmicity of these symptoms has led to the suggestion that disturbances in the biological clock may underly them. This is supported by both behavioural and molecular evidence [for reviews see (1, 2) ]. Behaviourally, patients with AD have been shown to have lower locomotor activity during the day and a higher percentage of their total daily activity at night relative to age-matched comparison subjects. The activity rhythms of AD patients have been reported to delayed by four hours in AD patients compared to normal elderly controls (3) (4) (5) AD patients also show less inter-daily stability (a measure of rhythmicity) and a later acrophase (time at which a peak of activity occurs) (3, 6) . Circadian rhythms are regulated by a master clock located in the suprachiasmatic nucleus (SCN) (7, 8) . Recently Videnovic et al., (1) showed in a small post-mortem sample of patients with AD and age-matched controls that SCN neuronal number correlated with the amplitude of the circadian rhythm of locomotor activity.Identification of neural and non-neural tissues that contain the molecular machinery required for the generation of endogenous rhythms has been made possible by the identification of clock genes (7).
These genes include Clock, Bmal1, Per1, Per2, Per3, Cry1, Cry2, Rev-Erb, Rev-Erbβ, Rora, Rorb and Rorc (9) . Through binding to E-box elements, Clock:Bmal1 heterodimers drive the expression of multiple Clockcontrolled genes (CCGs). As the Per and Cry protein products accumulate in the cytoplasm, they dimerize and translocate to the nucleus to inhibit the activity of Clock:Bmal1, thereby inhibiting their own transcription. Reverbα forms an additional negative loop to the cycle by inhibiting Bmal1 transcription. As a positive loop, Per proteins inhibit Rev-erb transcription; this lifts the Rev-erb mediated inhibition of Bmal1 transcription, which serves to activate the system (10) . It has now been established that individual cells possess self-sustained circadian oscillators and are not simply weak "slave" oscillators driven by the master SCN clock (11) . The discovery of SCN-independent brain clocks in a number of areas in the mammalian brain including the olfactory bulb, brainstem and hippocampus suggests that the mammalian circadian system involves multiple pacemaking nuclei (12, 13) . Little is known about the role of the relationship between extra SCN brain oscillators and rhythmic and circadian behavior and even less is known about whether there may be alterations in these oscillators that might play a role in rhythmic and circadian abnormalities in AD. It is notable that the hippocampus and olfactory bulb brain regions have been associated with the earliest stages of AD pathology (14) . have shown a generalised hyperactivity in AD mouse models with some studies showing this to be specific to nocturnal activity (16, 17) and some to diurnal activity (18, 19) . This variability is unsurprising given that studies differ in the transgenic model used (e.g. Tg2576, APPSwe/PS1dE9, APP23), background strain of mouse (e.g. C57BL/6, CD1/129) and method used to assess activity (e.g. running wheel vs. home cage).
Differences in the age at testing and whether studies have been carried out under free running vs entraining light-dark conditions also contribute to the variability in inferred phenotypes (20, 21) (22) (23) (24) . While the number of studies is as yet small, many do indicate some modest circadian abnormality when compared to wild-type controls that show greater consistency.
Several studies using different measurement techniques have shown that clock gene expression (mostly Per1
and Per2) varies across the 24 hour cycle in the SCN in mice (25, 26) and more recently in rats (27) . Wang et al., (28) showed that Per2 mRNA and protein expression varied across the 24 hour cycle in the hippocampus.
While these rhythms are altered with normal ageing in several species including mice, hamsters and rats (29) (30) (31) , few studies have investigated whether these expression patterns are altered in genetic mouse models relevant to AD. Duncan and colleagues (32) showed the clock gene Per2 is increased at night in the SCN of wild-type mice with a strong trend towards attenuation of this increase in APPxPS1 mice that did not reach statistical significance. The mice used in that study were on a CD1/129 background strain and notably did not show the hyperactivity frequently reported in APPxPS1 mice. The WT mice in that aspect of the study were also 15 months old, and as the study indicated age-associated reductions in activity rhythms it is possible that a floor effect may have masked potential changes associated with genotype for the baseline day/night changes in Per2. In the current study we investigated whether the 24hour rhythm of home cage activity is abnormal in APPSwe/PS1dE9 mice on the more common C57BL/6J background strain. We subsequently investigated whether these mice concomitantly show abnormalities in differential mRNA expression of a number of clock genes between the highest and lowest point of their activity in the 24 hour cycle; Zeitgeber times (ZT) 2 and 14 (day vs. night). Zeitgeber times were defined in relation to the light-dark cycle with ZT0 as lights on and LT12
as lights off. We focused on brain regions outside of the SCN: the hippocampus (important for memory function) and the medulla/pons (important for the sleep-wake cycle).
MATERIALS AND METHODS

Animals and housing conditions
The mice used in these studies were the double transgenic AD mouse model, APPswe/PS1dE9 and WT controls of the same C57/BL6 genetic background. A chimeric mouse/human APP695 with mutations linked to familial AD (APPSwe) was expressed as well as a mutation in the human PS1 gene carrying the exon-9-deleted variant associated with AD (33, 34) . All experimental animals used in the present work were bred in the University of Nottingham's transgenic animal facility and have been described previously (35, 36) . Prior to activity monitoring studies, all mice were housed in the same room, maintained on a light/dark (LD) light cycle, with lights on at 07:00 hrs. Room temperature, relative humidity and air exchange were automatically controlled.
Mice were housed in individually ventilated cages (Tecniplast, Buguggiate (VA), Italy) with a floor area 501cm, dimensions (WxDXH) 391X199x160 mm. Cages had a play tunnel and shredded paper nesting material. They were housed in groups of 2-3 with ad libitum access to food and water, and provided with nesting material and a play tube. During the studies, the animals were singly-housed and were subjected to either a LD cycle or constant dim red light ("darkness": DD Experiment 1: In the initial period of the study, the mice were under a 12h light: 12h dark cycle (lights on 07:00 hrs ZT12 lights off 19:00 ZT24) and locomotor activity was recorded for 6 days (8640 mins). Locomotor activity recording in DD for 24 days followed immediately, the mice remained in the experimental room, the fluorescent lights were turned off and red lights kept on permanently, the chamber doors were closed and a radio was permanently switched on which provided additional background noise (70 dB). This was done to ensure the elimination of all photic and non-photic cues associated with the building. At the end of the experiment, the mice were re-housed with their original littermates and returned to the holding room.
Analysis of locomotor activity data
The locomotor activity data was collected in 1 minute bins and several variables extracted and analyzed. For the purposes of this study, Diurnal distance was defined as activity that occurred in the light phase (07:00-19:00 hrs), Nocturnal activity was defined as activity that occurred in the dark phase (19.00 -07:00 hrs). Percentage of nocturnal activity refers to the percentage of total daily activity occurring during the nocturnal period (6).
Percentage of the first/last 2 hours in the light/dark period refers to the percentage of total daily activity occurring in the first/last 2 hours of the light/dark phases (32) . Period length was calculated using the Chi (37) . Period length under free-running conditions (DD) was calculated by visually fitting a line to the activity onsets, estimating the total phase shift over the course of the study, then calculating the mean shift per cycle. This was done by an experimenter who was blind to the genotype of the mice. Cosinor analysis fits a cosine wave to the raw data (37) . This yields the mesor (central point of the fitted cosinor function), amplitude (height of the fitted cosine curve), relative amplitude (amplitude/mesor) and acrophase (31) . The software used is available at http://www.circadian.org/softwar.html. Acrophase is the time at which the peak of a rhythm occurs. It refers to the phase angle of the peak of a cosine wave fitted to the raw data of a rhythm. The unit of measurement is degrees (°) which is converted to a value proportional to that of a 24-hour clock using the formula, H = (D x 24) / 360 + S, where D is the value in degrees, H is the value in hours, and S is the start time. Robustness has been described as how regular a circadian rhythm is and calculated as the percentage of the total variance that can be accounted for by the cosine wave (a measure of rhythmicity).
Essentially the robustness statistic reflects the extent of stationarity of a rhythm, a calculation of the periodograms Qp value compared to the Qp value associated with a perfectly rhythmic time series. (38) The Rhythmicity Index measured the strength of the rhythm calculated as the height of the third peak in an autocorrelation analysis (39) .
Activity Onset was determined as the first time-point from 6hrs before lights off where activity counts exceeded the 24 hrs mean and remained sustained over three of the following bins. This is dissociable from the onset of the active phase. Activity Offset was determined as the latest time-point with three of the previous bins also above the 24 hrs (23). This is dissociable from the end of the active phase. Activity Duration was calculated as the difference between Activity Onset and Activity Offset.
Under LD conditions, lights on was 07.00 hrs and lights off was 19.00 hrs. Mice are largely nocturnal and onset of the active phase is closely linked to lights off. However, as a result of the changes to onset/offset of the active phase under DD conditions and the fact that there are individual differences in the amount and direction of these shifts, onset and offset of the active phase can no longer be fixed to 07.00 and 19.00 hrs respectively and rhythms would be expected to free-run. This therefore means diurnal activity, nocturnal activity, percentage of activity at night and percentage of the first/last 2 hours in the light/dark period cannot be measured. Double plotted actograms were used to visually represent each day in DD (37) .
The number of total stereotypic counts (repeated movement within a specified area around the mouses location detected by the software) made by the mice was also recorded. Diurnal/ nocturnal stereotypic counts were Figure 1A shows that in 12L:12D conditions APPSwe/PS1dE9mice ('APPswe' in Figure) were In exploring the patterns of activity across the 24 hour period, APPSwe/PS1dE9 mice showed 
RESULTS
Locomotor Activity : LD conditions
Locomotor activity: DD conditions
In DD conditions APPSwe/PS1dE9 mice were also significantly more active that WT mice [F(1,12)=8.689, 
Clock Gene Expression
Effect of genotype
Expression levels of mRNA for 8 clock genes were investigated in two brain regions (hippocampus and medulla/pons) of wild-type and APPSwe/PS1dE9 mice at ZT2 and ZT14. A significant main effect of genotype on Cry1 (p=0.038) and Cry2 (p=0.035) was observed in the medulla/pons ( Figure 5B ).No significant effect of genotype was seen in the hippocampus. There were significant interactions between genotype and time of day (outlined below). In the hippocampus ( Figure 5A ) there was a general trend towards higher expression at ZT14 compared to ZT2, these levels reached significance for the Per1 (p=0.048) Per2 (p=0.032) and Rev-erb (p=0.041) expression. In the medulla/pons ( Figure 5B) , there was similarly a general trend towards higher expression at ZT14 compared to ZT2 these levels reaching significance for Per1 (p=0.006), Per 2 (p=0.023), Cry1 (p=0.008) and Cry2 (p=0.003).
Effect of time of day
Genotype x time of day interaction
In the medulla/pons, the effect of TOD on the expression of Cry1 (p=0.04), Cry2 (p=0.042), Clock (p=0.025) and Bmal1 (p=0.018) was significantly different in WT mice and APPSwe/PS1dE9 mice. In APPSwe/PS1dE9 mice, there was a significant down-regulation of Cry1 (p=0.045), Cry2 (p=0.03), Clock (p=0.05) and Bmal1 (p=0.03) gene expression at ZT14 compared to WT mice at ZT14.
DISCUSSION
These data indicate that APPSwe/PS1dE9 mice show locomotor hyperactivity, a finding consistent with a number of previous studies (23, (40) (41) (42) . This hyperactivity was manifest particularly at night as expected in Figure 4A for illustration). These indices taken together suggest abnormality in the circadian timing system in APPSwe/PS1dE9 mice. Shorter period length is reminiscent of effects found in several studies showing that period length shortens with age in many animal species (43) (44) (45) . This may be consistent with an accelerated aging effect in APPSwe/PS1dE9 mice. We did not however see the generalised fragmented circadian activity pattern frequently reported in studies in older mice e.g., (46) . There are some studies both in humans and mice that report a lengthening of the circadian period with age (47) . Methodological considerations have been highlighted as contributing to these variable findings including after-effects from the former LD conditions (46) .
Studies of patients with Alzheimer's Disease suggest increased activity at the end of the active phase (48), however it is clear that there is large individual variation in this pattern. In the present study while we found increased activity it is concentrated at the earlier rather than later part of the active phase. A shorter period length maybe a contributory factor to this effect. Clinical studies also show later acrophase in Alzheimer's patients while these mice show earlier acrophase. However direct transposition between behavioural endpoints in human clinical studies and those in mice must be drawn with caution. In patients the studies are necessarily carried out in LD conditions and there is considerable heterogeneity in age, diagnosis and sex. The present study was carried out in female mice only, while most patient studies include both sexes. One advantage of mouse models for examining questions abot circadian biology is that they can be carried out easily in free running conditions thereby assessing the endogenous free running rhythm. We have preliminary evidence from this study for a shortening of period length in DD conditions, which might suggest a potential mechanism to investigate in patient studies. For example further addressing the question of mechanism of circadian disruption in patients it would be of interest to investigate whether period length is shorter under LD conditions specifically in females.
Robustness of the circadian rhythm was significantly altered in DD compared to LD, resulting in the mice having a less robust rhythm in DD. However, RI (rhythmicity index) was unchanged under DD conditions.
Although robustness and RI both measure the presence and strength of the rhythm, they address different aspects. In robustness, a single cosine curve is fitted on to a mean of the days measured and gives the variance that can be accounted for by this curve. In RI, an autocorrelation comparison of elements within a series (i.e. across days) is performed. Thus, a high value of robustness refers to variance within the mean 24h period i.e. it is a smooth rhythm with minimal noise. APPSwe/PS1dE9 mice showed increased robustness of their activity Abnormality of the circadian system at the behavioural level is potentially supported by gene expression studies. Increases in clock gene expression at night (ZT14) versus day (ZT2) were found in mice sacrificed under LD conditions in both the hippocampus and the medulla/pons regions in these mice. This increase extends previous studies conducted in the SCN region of this strain of mice (32), and further indicates that changes in clock gene expression can be detected in multiple brain regions.
In APPSwe/PS1dE9 mice the ZT14 increase was blunted for Cry1 and Cry2 genes. Kume et al., (49) showed that mCRY1 and mCRY2 are potent inhibitors of CLOCK:BMAL1-mediated transcription. All of the four genes implicated in this loop of transcription regulation are differentially expressed in the medulla/pons at ZT14 in 2 months old APPSwe/PS1dE9 mice compared to WT mice at ZT14. Previous studies have shown that the medulla and pons play a critical role in promoting wakefulness (50, 51) . Patients with Alzheimer's disease suffer from a disrupted sleep-wake cycle (6, 52, 53) . It is possible that there is an association between these findings and the disrupted sleep-wake cycle observed in AD. Besides their role in directly inhibiting CLOCK:BMAL1-mediated transcription, (54), the mCRY proteins play a critical role in the translocation of mPER1 and mPER2 proteins from the cytoplasm to the nucleus (49).
In terms of the general effect of time of day (TOD), our study demonstrates that there was an increase in expression of Per1, Per2 and Rev-erb in the hippocampus at ZT14 compared to ZT2. We have also observed an increase in gene expression levels of Per1, Per2, Cry1 and Cry2 at ZT14 compared to ZT2 in the medulla/pons. Somewhat contrastingly, studies by (28) showed that peak expression of Per2 in the hippocampus was found between ZT23 and ZT2 while lowest expression was at ZT10. (12) showed that Per2 expression in the dentate gyrus, CA1 and CA3 sub-regions of the hippocampus peak at ZT22, ZT21.5 and ZT23.5 respectively in rats. It is difficult to make direct comparisons as the rodent species, age, method of expression measurement, time-point and brain tissue sampling technique differs from the present study. The study by (32) found a significant upregulation of Per2 expression in the SCN at ZT10 compared to ZT2 in APPSwe/PS1dE9 mice, which agrees with our findings in WT mice only. One crucial difference from the present study is a different background strain of mouse [c57BL/6 vs CD1/129]. Given that the WT expression patterns are similar between day and night between the studies, and differ in the effects of the transgene, epistatic effects of the transgene cannot be ruled out. There was no effect of genotype on any of the clock genes investigated in the hippocampus. Similarly, (32) found that Per2 expression in the hippocampus, cingulate cortex and motor cortex were not significantly affected by genotype or time of day. The overall expression level of clock genes relative to GAPDH was significantly lower in the hippocampus compared to the medulla/pons, which may have made it more difficult to detect changes, however we did show a clear day/night increase for Per1, Per2 and Rev-erb. An increase in
Per2 at night has recently been shown in a similar background strain and has been shown to be compromised by A31-35 peptide delivered directly into the hippocampus (55) . An increase in Rev-erb in the hippocampus at night replicates findings from (56) who showed this effect for both mRNA expression and protein levels in the hippocampus in WT mice of a similar background strain. This suggests these are robust effects. One limitation of the dissection technique we used is that we do not differentiate subregions with differing projection regions and functions. Thus, it is possible that while we could detect relatively large effects in the medulla/pons region, subtle effects in some hippocampal subregions or cell types in APPSwe/PS1dE9 might be more difficult to detect using this approach. One further limitation of the present study is that we were only able to assess two time points throughout the 24hr period. While we ensured to select points corresponding to the lowest and highest activity peaks, wider effects could be missed. Equally expression levels of different genes such as Clock and Bmal may have different rhythms in different tissues as has been suggested previously, the same time point may not be appropriate for all genes measured (29, 57) . In the light of these limitations, null results for any given gene or tissue in this study must be interpreted with caution.
Many studies have shown day-night rhythmicity of clock genes. For e.g. Harbour et al., (12) analysing Per2 expression in 20 forebrain areas showed that peak expression of Per2 immunoreactive cells in the SCN occurred in the early part of the dark phase, at ZT 14.25. Using transgenic rats expressing the firefly luciferase gene under the control of the mouse Per1 promoter, (25) investigated the intrinsic rhythmicity of Per1 in isolated brain regions. 14 out of 27 Per1 expressing regions were found to be rhythmic. Peak Per1 bioluminescence in the extra-SCN regions was in the dusk and at night while that in the SCN was in the day. This is consistent with our findings of a night-time increase although (25) failed to show intrinsic rhythmicity in the hippocampus, median (MR) and dorsal (DR) raphe, substantia nigra (SN) and ventral tegmental area (VTA) regions of the midbrain.
Using siRNA-mediated gene dosage analysis, (58) showed that expression of clock genes responds to genetic perturbations in a compensatory manner. For example, they found that Cry2 was upregulated proportionally when Cry1 was knocked down in a dose-dependent manner. Also, down regulation of Bmal1 by of diurnal rhythmic expression of hBmal1, hCry1 and hPer1 in the pineal gland (which secretes melatonin) of both preclinical (Braak stages I-II) and clinical AD subjects (Braak stages V-VI) (59) . This loss of clock gene rhythmicity in the pineal gland is associated with a dramatic decrease in nocturnal melatonin concentrations as well as a loss of the circadian rhythm in melatonin production (60, 61) .
The APPSwe/PS1dE9 mice used in the present experiment were tested at 2 months of age. Typically these mice display Aβ deposition by 4 months with the appearance of plaques from 6 up to 12 months accompanied by concomitant increase of Aβ levels. Behavioural deficits such as memory deficits typically manifest at 5-6 months of age (35, 62, 63) . This suggests that the effects we may not be consequent to amyloid plaques. One pathology that has been described for these mice at a similarly young age is abnormal long-term potentiation, a neuronal phenomenon proposed to be a synaptic index of learning (64) but not seen in all studies (65) . Increased levels of oligomeric Aβ have been observed in young "pre-plaque" mice of a similar age (PND60), while neurogenesis in the dentate gyrus area of the hippocampus has been also been shown to be reduced in APPSwe/dE9 mice (65). Busche et al (66, 67) showed in an APP/PS1 AD mouse model that plaque formation is preceded by specific neural hyperactivity (in these experiments in the hippocampus) possibly via a soluble A mechanism. These changes may be of interest to explore in the context of the behavioural changes we report, as they are detectable at an age that has consistently been shown to be prior to plaque pathology or profound memory deficits. Our unpublished preliminary data for 9month APPSwe/PS1dE9 males suggest that the behavioural abnormalities we report here are also seen in males at an older age suggesting the effect persists beyond that at which amyloid plaque deposition occurs.
The present study was carried out in female mice only. Whether these results generalise to young males remains to be investigated. Sex differences have been reported for APPSwe/dE9 mice in the amount of Aβ deposited though this has been measured at 4 months of age (68) or across a range of ages [2-5 months] (69). At 4 months of age, females show higher levels of Aβ40 and Aβ42 in the hippocampus (68) . This might explain why we have been able to detect such early behavioural changes compared to prior studies that have used mixed sex cohorts.
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